In vitro activity of ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae in Greece: A single-centre study

J Glob Antimicrob Resist. 2020 Mar:20:82-83. doi: 10.1016/j.jgar.2019.11.021. Epub 2019 Dec 9.

Authors

Efthymia Protonotariou¹, Georgios Meletis², Melania Kachrimanidou³, Dimitra Papadopoulou¹, Aikaterini Stamou¹, Maria Arhonti¹, Lemonia Skoura¹

Affiliations

¹ Department of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, Thessaloniki, 54636, Greece.
² Department of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, Thessaloniki, 54636, Greece. Electronic address: [email protected].
³ First Department of Microbiology, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.

PMID: 31821890
DOI: 10.1016/j.jgar.2019.11.021

No abstract available

Publication types

Letter

MeSH terms

Azabicyclo Compounds / pharmacology*
Bacterial Proteins / genetics*
Ceftazidime / pharmacology*
Drug Combinations
Drug Resistance, Bacterial / drug effects
Greece
Humans
Klebsiella Infections / drug therapy
Klebsiella Infections / microbiology*
Klebsiella pneumoniae / drug effects*
Klebsiella pneumoniae / isolation & purification
Microbial Sensitivity Tests
beta-Lactamases / genetics*

Substances

Azabicyclo Compounds
Bacterial Proteins
Drug Combinations
avibactam, ceftazidime drug combination
Ceftazidime
beta-Lactamases
carbapenemase